Navigation Links
New Jersey Dietetic Association Names Ketchum's Jaime Schwartz Young Dietitian of the Year
Date:7/21/2009

NEW YORK, July 21 /PRNewswire/ -- The New Jersey Dietetic Association (NJDA) awarded Jaime Schwartz the Young Dietitian of the Year Award for her achievements since becoming a registered dietitian (RD) in 2002.

Schwartz, an account supervisor in the Food & Well-Connected Practice at Ketchum, a global public relations agency, was presented the award at NJDA's annual meeting on May 8, where she was also featured in a panel discussion, "RDs Breaking Barriers: An Inside Look at Nontraditional Careers and How to Get There."

Over the course of Schwartz's young career, the past three years of which have been at Ketchum's New York office, she has emerged as an up-and-coming leader in the dietetics profession.

Among her contributions to the profession, Schwartz has served in these roles:

  • Mentoring chair of the Dietitians in Business and Communications practice group
  • Co-editor of the NJDA quarterly newsletter News & Views
  • Secretary of Penn State's Nutrition and Dietetics Alumni Society
  • Lead author of research published in professional journals about "portion distortion," nutritional labeling and portion-size measurement aids

The award also recognized her client work at Ketchum. In her unique role as an RD in public relations, Schwartz leads the professional education activities for large food corporations, helping to create valuable educational opportunities, including symposiums and webinars, for thousands of RDs every year. She also oversees the development of tools important to nutrition educators. In addition, Schwartz was recognized for helping to create opportunities for RDs to gain visibility as the go-to source for nutrition information.

S
'/>"/>

SOURCE Ketchum
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Video: Circulatory Care of New Jersey
2. Keane Wins $1 Million Electronic Medical Record (EMR) Implementation at New Jersey-Based Acute Care Facility
3. First New York/New Jersey Health Care Report Card Released
4. New Jersey Physicians Launch New, Statewide Association to Fight for Stronger Voice in Healthcare
5. New Jersey Nets Shoot Down Staph with High-Tech Defense
6. Filing for Reconsideration/Press Conference ACUNA v. TURKISH, Historic Informed Consent Abortion Case to the New Jersey Supreme Court
7. New Jersey Entrepreneur Turns a Page for Four National Charities
8. FDA Inspects Hoviones Technology Transfer Center in New Jersey
9. New Poll Finds Nearly Seven in 10 New Jersey Voters Support Smoke-Free Casinos
10. Distinctive Art Auction Supports American Red Cross of Central New Jersey
11. Keisha Orr of Edgewater Park, New Jersey is Named Philadelphias 2007 Local Loser

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...,, SANDIEGO,Nov.23/PRNewswire/--VictoryPharma,I...74;DoseCard,afurtherextensionofVictory,sNAPRELANfr...tswhorequirerelieffrommildtomoderatepainandinflamm...initisandbursitis.Itisalsodesignedforpatientssuffe...ereceivingothertherapiesandneedadditionalanti-infl...
(Date:11/23/2009)...pert says findings support link between mental and...althDay News) -- Being depressed might take as man... suggests. , However, a combination of depressi...than just depression. , Researchers came to the... survey of more than 60,000 people. During the fou...
(Date:11/23/2009)...most 20 percent get infected within one year of st...MONDAY, Nov. 23 (HealthDay News) -- As many as one...ansmitted disease (STD), many infected soon after ...ort shows. , "The high burden of STDs among tee...d study author Dr. Sami L. Gottlieb, from the divi...
(Date:11/23/2009)...Women who store fat on their waist in middle age a...hen they get older, reveals a new study from the S...blished in the scientific journal Neurology . , ...s at greater risk of dying prematurely due to a he...ior lecturer at the Sahlgrenska Academy. "If they ...
(Date:11/23/2009)...MAYWOOD, Il. -- A Loyola University Health System ...ics is morbidly obese -- approximately 100 pounds ...62.4 percent of U.S. adults with Type 2 diabetes a...ng African American adults with Type 2 diabetes, 1...besity among people with diabetes is increasing at...
Breaking Medicine News(10 mins):Health News:Victory Pharma, Inc. Announces Launch of NAPRELAN(R) Dose Card 2Health News:Depression May Up Death Risk to That of Smoking 2Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Diabetics show alarming increase in morbid obesity 2
... A Lifeclinic LC300 automated blood pressure ...me talk show, The Doctors. The series airs each we...m a panel of four practicing medical professionals... on the new CBS daytime talk show, The Doctors. Th...
...ded and gsi interactive Named as Digital Marketing...TSBURGH, Pa., Dec. 16 GSI Commerce Inc. (Nasdaq: ...tichannel solutions, today announced a multiyear e...lements. Under the agreement, which runs through ...
... reach immune cells in just 4 hours , , TU...male-to-female transmission of HIV -- in which the...reach immune cells in just four hours -- has been ...tercourse, because the large HIV virus couldn,t pe...
...., Dec. 16 Third Brigade,( http://www.thirdbrigad...ion,for dynamic datacenters, today announced that ...eployed Third Brigade Deep Security for increased,...l,data resulting from nearly three quarters of a m...
...ty letter scores increased similarly in all treatm...swire-FirstCall/ - QLT Inc. (NASDAQ: QLTI ; TSX:...terim analysis for the Phase II RADICAL study (Red... study comparing reduced-fluence Visudyne(R)-Lucen...
... CeloNova BioSciences, Inc., announced,today that ...e U.S. Food and,Drug Administration (FDA) for Embo...icated for the treatment of hypervascularized tumo...l sales of,Embozene(TM) Microspheres will begin im...
Other Medicine News:Health News:Benefits of a Lifeclinic LC300 Automated Blood Pressure Monitor Recently Featured on Daytime Medical Talk Show 2Health News:GSI Commerce and GNC Corporation Extend E-Commerce Agreement Through 2017 2Health News:GSI Commerce and GNC Corporation Extend E-Commerce Agreement Through 2017 3Health News:HIV Can Penetrate a Woman's Healthy Genital Skin 2Health News:Beth Israel Deaconess Medical Center Maintains Healthy IT Servers With Third Brigade 2Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 2Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 3Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 4Health News:QLT announces interim results of radical study evaluating Visudyne combination therapy 5Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 2Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 4
(Date:11/23/2009)...wire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS )ann...nerRoche(SWX:ROG.VX;RO.S,OTCQX:RHHBY),willcontinue...gphase2btrialofRG7128,afirst-in-classnucleosideana...titisCvirus(HCV)infection.Thedecisionwasreachedaft...mittee(DMC)ofallavailablesafetydatafromthefirstcoh...
(Date:11/23/2009)....23/PRNewswire-FirstCall/--CeptionTherapeutics,Inc...on,Inc.(Nasdaq: CEPH )todayannouncedresultsfromaPh...satreatmentforpediatriceosinophilicesophagitis(EoE...primaryendpointsofchangesinesophagealeosinophillev...hatpatientstreatedwithCINQUILshowedastatisticallys...
(Date:11/20/2009)...wswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq...l first quarter ended September 30, 2009. ,, ...nue decreased approximately $234,000, or 2.7%, to ...tember 30, 2009 as compared to the same period las... net revenue of $8,434,000 compared with $8,669,00...
Breaking Medicine Technology:Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 2Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 3Pharmasset Announces the Continued Enrollment of the Phase 2b Clinical Trial of RG7128 for the Treatment of Hepatitis C 4Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 2Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 3Ception Therapeutics and Cephalon Provide Initial Results of a Phase IIb/III Study of CINQUIL in Pediatric Eosinophilic Esophagitis 4Escalon(R) Reports First Quarter Fiscal 2010 Results 2Escalon(R) Reports First Quarter Fiscal 2010 Results 3Escalon(R) Reports First Quarter Fiscal 2010 Results 4Escalon(R) Reports First Quarter Fiscal 2010 Results 5Escalon(R) Reports First Quarter Fiscal 2010 Results 6Escalon(R) Reports First Quarter Fiscal 2010 Results 7Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 1Caraco Pharmaceutical Laboratories Ltd Announces Filing of Purported Class Action Lawsuits 52622 2Carnegie Mellon team makes sequestration recommendations 9339 1Carnegie Mellon team makes sequestration recommendations 9339 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3
...da and Scripps Research in La ...and LA JOLLA, Calif., May 14 /PRNewswire-,FirstCal... ), a,biopharmaceutical company focused on oncolog...t biomedical research organization, today announce...asses of protein kinase,inhibitors for the treatme...
...ncorporated (Nasdaq: KOSN ) today announced that ...e company,s lead Hsp90 inhibitor, from a Phase,2 t...with HER2-positive,metastatic breast cancer, at th...linical Oncology (ASCO), being held at McCormick P...bstract 1027, titled, "Phase 2 trial of the Hsp90 ...
Other Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 2Kosan Announces Data Presentations at ASCO 2008 Annual Meeting 3
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
...ratories is a national reference laboratory and a ... and development. ARUP offers an extensive test me...linical and anatomic pathology. Owned by the Unive...more than half of the nation's university teaching...
Medicine Products: